期刊文献+

重组人碱性成纤维细胞生长因子的纯化及生物活性鉴定 被引量:4

Purification and bioactivity detection of recombinant human basic fibroblast growth factor
下载PDF
导出
摘要 目的 :探讨重组人碱性成纤维细胞生长因子 (rhbFGF)的纯化工艺和活性鉴定 .方法 :将rhbFGF工程菌大量扩增后通过包涵体提取、复性、阳离子交换、凝胶过滤等技术进行纯化 .结果 :纯化后的rhbFGF ,相对分子质量为 17× 10 3,蛋白纯度为 95 %以上 ,比活为 1 7× 10 6 U/mg ,对NIH3T3细胞具有明显的促分裂活性 .结论 :通过复性和两步层析的纯化方法可获得高纯度、高回收率和高生物活性的rhbFGF 。 Aim: Purification and bioactivity detection of recombinant human basic fibroblast growth factor. Methods: rhbFGF was purified from rhbFGF producing BL21(DE3) bacteria. The inclusion bodies were first extracted and followed by cation-exchange chromatography and gel filtration. The bioactivities were detected by MTT assay. Results: rhbFGF was obtained with a purity above 95 percent, molecular weight is 1 7×10 3, and specific activity 1 7×10 6 U/mg. It enhances significantly the multiplication of 3T3 cells. Conclusion: rhbFGF of high purity and high bioactivity can be obtained by refolding of inclusion bodies and two steps of purification. The high yield and good quality of rhbFGF are important both for laboratory and the clinical application.
出处 《暨南大学学报(自然科学与医学版)》 CAS CSCD 2002年第3期111-115,共5页 Journal of Jinan University(Natural Science & Medicine Edition)
基金 国家 8 6 3项目 (Z18- 0 3- 2 9)
  • 相关文献

参考文献2

二级参考文献1

  • 1Portia B. Gordon,Ira I. Sussman,Victor B. Hatcher. Long-term culture of human endothelial cells[J] 1983,In Vitro(9):661~671

共引文献17

同被引文献43

  • 1Cmnauer M V, Schtdz W A, Seifert H H, et al. Fibroblast growth factors and theix receptors in urctlogical cancers: Basic research and clinical implications.European Urology,2003.433(3) :309 - 319.
  • 2Nakatake Y,Hoshikawa M,Asaki T,et al.Identification of a novel fibroblast growth factor.FGF-22,preferentially expressed in the inner root sheath of the hair follicle. Biochem Biophys Acta, 2001,1517:460 -463.
  • 3Yamashita T, Yoshioka M, Itoh N. Identiticafion of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem Biophys Res Commun,2000,277:494-498.
  • 4Leo D Thompson, Michael W Pantoliano, Barry A Spinger. Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain.Biochemistry, 1994,33:3831 - 3840.
  • 5William F Health, Amanda S Cantrell, Nancy G Mayne, et al.Mutations in the heparin-binding domains of hmnan basic fibroblast growth factor alter its biological activity. Biochemistry, 1991,30(22) :5608 - 5615.
  • 6Jiandong Zhang, Lawrence S Cousens, Phillip J Barr, et al. Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 113. Proc Natl Acad Sci USA,1991,88(8) :3446-3450.
  • 7Eriksson A E, Cousens L S,Weaver L H,et al. Three-dimensional structure of human basic fibroblast growth factor. Proc Nail Acad Sei USA,1991,88(8):3441-3445.
  • 8Li Lu-yuan, Michal Safran, David Aviezer, et al. Diminished heparin binding of a basic fibroblast growth factor mutant is associated with reduced receptor binding, mitogenesis, plasminogen activatorinduction, and in vitro angiogenesis. Biochemistry, 1994, 33 (36) :10999-11007.
  • 9Sambrook J, David W Russell. Molecular Cloning: A Laboratory Manual. 3 ed. Beijing: Science Press, 2002.1109-1113.
  • 10Cronauer MV,Schulz WA,Seifert HH,et al.Fibroblast growth gactors and their receptors in urological cancers:basic research and clinical implications[J].European Urology,2003,433(3):309 -319.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部